(a) A prescribing practitioner, as defined in section 20-14c, who is authorized to prescribe an opioid antagonist, as defined in section 17a-714a, and a pharmacy may enter into an agreement for a medical protocol standing order at such pharmacy allowing a pharmacist licensed under part II of this chapter to dispense an opioid antagonist that is (1) administered by an intranasal application delivery system or an auto-injection delivery system, (2) approved by the federal Food and Drug Administration, and (3) dispensed to any person at risk of experiencing an overdose of an opioid drug, as defined in 42 CFR 8.2, or to a family member, friend or other person in a position to assist a person at risk of experiencing an overdose of an opioid drug.
(b) Any such medical protocol standing order shall be deemed issued for a legitimate medical purpose in the usual course of the prescribing practitioner's professional practice. The pharmacy shall provide the Department of Consumer Protection with a copy of every medical protocol standing order agreement entered into with a prescribing practitioner under this section.
(c) A pharmacist may only dispense an opioid antagonist pursuant to a medical protocol standing order if the pharmacist has been trained and certified as part of a program approved by the Commissioner of Consumer Protection.
(d) A pharmacist who dispenses an opioid antagonist pursuant to a medical protocol standing order shall (1) provide appropriate training regarding the administration of such opioid antagonist to the person to whom the opioid antagonist is dispensed, (2) maintain a record of such dispensing and the training required pursuant to this chapter, and (3) send a copy of the record of such dispensing to the prescribing practitioner who entered into an agreement for a medical protocol standing order with the pharmacy.
(e) A pharmacist who dispenses an opioid antagonist in accordance with the provisions of this section shall be deemed not to have violated any standard of care for a pharmacist.
(f) The commissioner may adopt regulations, in accordance with chapter 54, to implement the provisions of this section.
(P.A. 17-131, S. 12.)
Structure Connecticut General Statutes
Section 20-570. - Short title: Pharmacy Practice Act.
Section 20-571. (Formerly Sec. 20-184a). - Definitions.
Section 20-572. (Formerly Sec. 20-163). - Commission of Pharmacy. Appointment and term of members.
Section 20-573. (Formerly Sec. 20-165). - Meetings of commission. Records.
Section 20-574. (Formerly Sec. 20-164a). - Supervision by Commissioner of Consumer Protection.
Section 20-575. - Powers and responsibilities.
Section 20-576. (Formerly Sec. 20-164). - Regulations.
Section 20-576a. - Acceptance and disposal of unused prescription drugs at pharmacies. Regulations.
Section 20-578. (Formerly Sec. 21a-306). - Information not to be disclosed. Exception.
Section 20-580. (Formerly Sec. 20-167). - Revocation or suspension of nonlegend drug permit.
Section 20-581. (Formerly Sec. 20-185). - Penalty for violation of Pharmacy Practice Act. Exception.
Section 20-582. (Formerly Sec. 20-176). - Appeals of decisions of Commission of Pharmacy.
Section 20-583. - Where appeals returnable.
Section 20-591. - Graduates of foreign pharmacy schools. Regulations.
Section 20-596. (Formerly Sec. 20-168b). - Ownership of pharmacies by prescribing practitioners.
Section 20-598. (Formerly Sec. 20-177). - Registration of pharmacy interns.
Section 20-598a. - Registration and certification of pharmacy technicians.
Section 20-599. (Formerly Sec. 20-174a). - Continuing education: Definitions.
Section 20-605. - Practice of pharmacy without license or temporary permit prohibited.
Section 20-606. (Formerly Sec. 20-178). - Use of the title “pharmacist”.
Section 20-611. (Formerly Sec. 20-175b). - Advertising legend drug prices.
Section 20-612. - Only pharmacy may accept prescription for dispensing.
Section 20-617a. - Flavoring agent added to prescription product.
Section 20-618. (Formerly Sec. 21a-107). - Repackaged drugs not considered misbranded, when.
Section 20-623. - Sale of nonlegend drugs. Labels, packaging and contents. Penalty.
Section 20-624. - Permit to sell nonlegend drugs.
Section 20-625. - Nonlegend veterinary drugs.
Section 20-626. - Confidentiality of pharmacy records.
Section 20-627. - Nonresident pharmacy. Definitions. Certificate of registration. Requirements.
Section 20-628. - Shipping, mailing or delivering legend devices or drugs.
Section 20-630. - Advertising.
Section 20-633. - Administration of vaccines by licensed pharmacists. Regulations.
Section 20-633a. - Pharmacy rewards program. Plain language summary. Violation.
Section 20-633b. - Sterile compounding pharmacies. Requirements. Regulations.
Section 20-633c. - Prescribing of opioid antagonists by licensed pharmacists. Regulations.
Section 20-633i. - Issuance of prescriptions for epinephrine auto injectors by pharmacists.
Section 20-636. - Sign re storage and disposal of prescription drugs.